0.9% Sodium Chloride (sodium chloride) NDC 51662-1577

Product information

Brand name (proprietary)

0.9% Sodium Chloride

Generic name (nonproprietary)

sodium chloride

Active ingredients

Sodium chloride — 9 mg/mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

HF Acquisition Co LLC, DBA HealthFirst

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207310

Marketing start

Jul 17, 2021

Listing expires

Dec 31, 2026

Other FDA classes

Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)

Identifiers

Product ID 51662-1577_c755e41b-acbb-7234-e053-2995a90aff0fSPL ID c755e41b-acbb-7234-e053-2995a90aff0fSPL set ID c755e41b-acba-7234-e053-2995a90aff0fRxCUI 1807634UNII 451W47IQ8X

Pharmacologic class

Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662157701 followed by a unit qualifier and the quantity Copy

Package 51662-1577-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207310

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.